Public source
Reviewed 3 Jun 2026
Completeness Fair (31%)
Cleo Skin
PrimaaCleo Skin is an AI powered primary diagnostic solution for clinical use in automated detection and quantification of tumor biomarkers in skin tissue
Cleo Skin is designed to detect presence or absence of dedicated biomarkers of skin tissue lesions, based on numerized image analysis of histological Whole Slide image (WSI or digitized slides of histological tissue samples).
Cleo Skin provides pathologists with an automatic reading of skin cancer diagnosis.
Cleo Skin is intended to be used as an aid to diagnosis and its results must be reviewed by accredited doctors.
No papers to support — we monitor for new evidence.
General Information
Product name
Company
Modality
Main task
Subspeciality
Organ/Specimen source
Not specified
Disease targeted
Specimen type
Not specified
Staining
Stain subtype
Not specified
Regulatory Information
Pathway:
In Vitro Diagnostic Regulation (IVDR)
Class:
Class C
Not verified by Health AI Register
Scanner Brands Certified for Use (CE-IVD)
Not specified
Scanner Models Certified for Use (CE-IVD)
Not specified
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Patient population age
Not specified
Input
Not specified
Input format
Not specified
Output
Not specified
Output format
Not specified
Integration
Not specified
Deployment
Not specified
Trigger for analysis
Not specified
Processing time
Not specified
Population
Not specified
Viewer systems
Not specified
Market Presence
On market since
Not specified
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Public | First published: Apr 22, 2026 | Last updated: Jun 3, 2026